Summary
Dr Paul Turner is a Reader/Clinician Scientist and Honorary Consultant at Imperial, and Clinical Associate Professor at the University of Sydney, Australia. His research, funded by the Medical Research Council, European Commission and UK Food Standards Agency among others, focusses on the pathophysiology of severe allergic reactions to food. He is a member of the UK Food Standards Agency's Science Council, the United Nations Food & Agriculture Organization and World Health Organization Codex Expert Consultation on Risk Assessment of Food Allergens, and leads the EAACI Taskforce on Food Allergen Thresholds.
Paul trained in Paediatric Allergy and Immunology in Sydney (where he was mentored by Andrew Kemp and Dianne Campbell) and Great Ormond Street Hospital, London. He is a graduate of Oxford University and the University of London, and undertook a PhD investigating the immunopharmacology of allergic rhinitis under John Foreman (University College London) and Glenis Scadding (Royal National Throat Nose & Ear Hospital).
Paul leads the food allergy desensitisation programme at St Mary's Hospital, London; the team was awarded the Best UK Clinical Team by Allergy UK in 2018. Paul was the recipient of the 2020 PhARf Award, awarded by the European Academy of Allergy and Clinical Immunology (EAACI). He is a consultant to the UK Health Security Agency, and Chairperson of the World Allergy Organization (WAO) Anaphylaxis Committee. He co-leads the Anaphylaxis Working Group at the Resuscitation Council UK.
Paul is an active member and ex-chairperson of the BSACI Paediatric Allergy Group, where he has led the project to institute nationwide Allergy Action Plans for children with life-threatening allergies (see www.sparepensinschools.uk). He is also an advisor to Allergy UK, and the Anaphylaxis Campaign. He teaches on a number of University Courses including the MSc in Allergy at Imperial College, and is a renowned speaker at international meetings.
Publications
Journals
Ruth E, Heraghty F, Flynn N, et al., 2023, No evidence of isotretinoin sensitization in peanut-allergic children: a cross-sectional study., Br J Dermatol, Vol:189, Pages:481-482
Greenhawt M, Dribin TE, Abrams EM, et al., 2023, Updated guidance regarding the risk ofAllergic reactions to COVID-19 vaccines and recommended evaluation and management: a GRADE assessment, and international consensus approach., Journal of Allergy and Clinical Immunology, Vol:152, ISSN:0091-6749, Pages:309-325
Turner P, Mamula J, Laktabi J, et al., 2023, How common are allergic reactions during commercial flights? A systematic review and meta-analysis, Journal of Allergy and Clinical Immunology: in Practice, ISSN:2213-2198
Turner P, Patel N, Blumchen K, et al., 2023, Impact of using less objective symptoms to define tolerated dose during food challenges: a data-driven approach, Journal of Allergy and Clinical Immunology, Vol:152, ISSN:0091-6749, Pages:145-154
Turner P, Patel N, Isaacs E, et al., 2023, Optimal dose of adrenaline auto-injector for children and young people at risk of anaphylaxis: a phase IV randomised controlled crossover study, Allergy, Vol:78, ISSN:0105-4538, Pages:1997-2006